3 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 57, n° 4
pages 588-593 (octobre 2007)
Doi : 10.1016/j.jaad.2007.03.004
accepted : 6 Mars 2007

Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: The effect of UVB dose and skin color

Laura A.G. Armas, MD a, , Susan Dowell, RN, PhD a, Mohammed Akhter, PhD a, Sowjanya Duthuluru, MD a, Christopher Huerter, MD a, Bruce W. Hollis, PhD b, Richard Lund, MD a, Robert P. Heaney, MD a
a Creighton University Medical Center, Omaha, Nebraska 
b Medical University of South Carolina, Charleston, South Carolina 

Correspondence to: Laura A. G. Armas, MD, Creighton University Medical Center, 601 North 30th St, Suite 4820, Omaha, NE 68131.

Ultraviolet (UV)-B light increases vitamin D levels, but the dose response and the effect of skin pigmentation have not been well characterized.


We sought to define the relationship between UVB exposure and 25-hydroxyvitamin D (25-OH-D) concentrations as a function of skin pigmentation.


Seventy two participants with various skin tones had 90% of their skin exposed to UVB light (20-80 mJ/cm2) 3 times a week for 4 weeks. Serum 25-OH-D was measured weekly.


Eighty percent of the variation in treatment response was explained by UVB dose and skin tone. Therapeutically important changes in 25-OH-D were achieved with minimal tanning.


Four weeks was not long enough to reach a steady state at the higher dose rates.


The response of 25-OH-D levels to UVB light is dependent on skin pigmentation and the amount of UVB given, and useful increases in vitamin D status can be achieved by defined UVB doses small enough to produce only minimal tanning.

The full text of this article is available in PDF format.

Abbreviations used : L, 25-OH-D, PTH, UV

 Supported by Dialysis Clinics Inc, The Endocrine Fellows Foundation, and research funds of Creighton University.
 Disclosure: Dr Hollis is a consultant for Diasorin. Diasorin manufactures assays for 25-hydroxyvitamin D. Drs Armas, Dowell, Akhter, Duthuluru, Huerter, Lund, and Heaney have no conflicts of interest to declare.
 Reprints not available from the authors.

© 2007  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline